The Chart of the Day belongs to the pharmaceutical ... The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic ...

The Chart of the Day belongs to the pharmaceutical company Eton ... The company offers ALKINDI SPRINKLE, a replacement ...

Crinecerfont is the first new treatment in 70 years for classic CAH and the only one that directly reduces excess ...

Adrenal mass malignancy predictors included rapid growth rate, hormonal overproduction, and right-sided laterality.

Immune-mediated colitis occurred in 0.4% (1/223, Grade 1) of patients receiving UNLOXCYT. UNLOXCYT can cause primary or secondary adrenal insufficiency. For Grade 2 or higher adrenal insufficiency, ...

Neurocrine Biosciences, Inc. (NBIX) said that the U.S. Food and Drug Administration has approved CRENESSITY (crinecerfont) capsules ...

Immune-Mediated Endocrinopathies Adrenal Insufficiency:IMFINZI and IMJUDO can cause primary or secondary adrenal insufficiency. For Grade 2 or higher adrenal insufficiency, initiate symptomatic ...

Patients with adrenal insufficiency had worse outcomes than those without adrenal insufficiency when hospitalized for STEMI. Among patients with ST elevation myocardial infarction (STEMI), comorbid ...

RAHWAY, N.J., November 19, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the pivotal Phase 3 MK ...